Gilead Sciences GILD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.22B+8.3% | $8.51B+4.9% | $8.11B+28.5% | $6.31B+5.8% | $5.97B+1,143% | ||
| $903M+1.0% | $894M+0.9% | $886M+1.6% | $872M+1.8% | $857M+2.6% | ||
| $10.81B+7.9% | $10.02B+3.6% | $9.67B-2.0% | $9.87B-4.8% | $10.37B-4.3% | ||
| $576M+2.3% | $563M+11.5% | $505M+1.2% | $499M-4.4% | $522M-0.2% | ||
| $906M-15.3% | $1.07B+99.6% | $536M-42.9% | $939M-12.2% | $1.07B-77.9% | ||
| -$2.61B+45.6% | -$4.79B-50.6% | -$3.18B+8.2% | -$3.47B-109% | -$1.66B+52.0% | ||
| $4.03B+0.7% | $4B+0.5% | $3.98B+0.6% | $3.96B+0.6% | $3.94B+0.5% | ||
| $1.61B-16.2% | $1.92B-5.9% | $2.04B+7.1% | $1.91B+28.9% | $1.48B+28.7% | ||
| -$8.56B-10.5% | -$7.75B— | —— | —— | —— | ||
| —— | —— | —— | $2.37B-26.1% | $3.21B-17.9% | ||
| $10.23B+8.2% | $9.46B+3.2% | $9.16B-2.2% | $9.37B-4.8% | $9.84B-4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gilead Sciences generate?
- Gilead Sciences (GILD) generated $10.8B in operating cash flow over the trailing twelve months.
- What is Gilead Sciences's free cash flow?
- After $576.0M of capital expenditures, Gilead Sciences's free cash flow was $10.2B over the trailing twelve months, up 3.9% year over year.
- Where does Gilead Sciences's cash flow data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
